| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.32 | 0.05 |